Related Experiment Video

Updated: Dec 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K

Novel modeling methodologies for the neuropathological dimensions of Parkinson's disease

Panagiotis Vlamos1

  • 1Department of Informatics - Ionian University, Corfu, Greece.

AIMS Neuroscience
|July 2, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.9K
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
06:09

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

4.9K

Related Experiment Videos

Last Updated: Dec 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.9K
Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
06:09

Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis

Published on: February 2, 2021

4.9K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Neural Regulation01:37

Neural Regulation

42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

835
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
835

Articles linked to this work by shared authors, journal, and citation graph.

A Structured Computational Roadmap for Lipidomics in R: Reproducible Workflows from Raw Data to Functional Insight.

Metabolites·2026

CpGene: a web application for epigenetic signature identification from DNA methylation arrays.

Bioinformatics (Oxford, England)·2026

Merging multimodal digital biomarkers into "Digital Neuro Fingerprints" for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI.

Frontiers in digital health·2026

AI agents in Alzheimer's disease management: challenges and future directions.

Frontiers in aging neuroscience·2026

Digital Accessibility for Students with Disabilities and Inclusive Learning in Education.

Advances in experimental medicine and biology·2026

Data-Driven Precision Learning: Transforming Adult Education with AI and Analytics.

Advances in experimental medicine and biology·2026

Association between TNFa rs1800629 and migraine: Case-control study and updated meta-analysis.

AIMS neuroscience·2026

Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment.

AIMS neuroscience·2026

Combining exercise and hypoxia for brain health: from elite athlete altitude training camps to clinical applications.

AIMS neuroscience·2026

Cutting-edge transformer-based deep learning for Parkinson's disease diagnosing using multimodal hand-drawing and handwriting analysis.

AIMS neuroscience·2026

An energy-gradient theory of embedded predictions in the brain.

AIMS neuroscience·2026

Neural changes to transcranial alternating current stimulation in the gamma range over the left frontoparietal network: A preliminary eLORETA EEG study.

AIMS neuroscience·2026

Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections.

Journal of clinical pharmacology·2026

[Drug Discovery - A surge in innovation driven by technology and artificial intelligence].

Therapeutische Umschau. Revue therapeutique·2026

Efficacy of nipocalimab in patients with moderate-to-severe ocular symptoms of generalized myasthenia gravis in the phase 3 Vivacity-MG3 study.

Expert opinion on biological therapy·2026

Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned.

Neurological research and practice·2026

Exposure Robustness by Design: a translational framework for oral drug product development.

Drug discovery today·2026

VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Neuroscience·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us